How Biomarker-Based Diagnosis and Treatment Affect Alzheimer’s Stigma: Results of a Randomized Trial

Alzheimer’s disease (AD) causes progressive disability and, ultimately, death. Currently no therapy can delay or slow cognitive and functional decline. This prognosis contributes to the general public’s negative reactions—discrimination, pity, and social distance—toward individuals with AD and their...

Descripción completa

Detalles Bibliográficos
Autores principales: Stites, Shana, Gill, Jeanine, Largent, Emily, Harkins, Kristin, Krieger, Abba, Karlawish, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682712/
http://dx.doi.org/10.1093/geroni/igab046.926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682712/
http://dx.doi.org/10.1093/geroni/igab046.926

Ejemplares similares